영양유전체학 시장 규모, 점유율, 성장 분석 : 제품별, 기술별, 용도별, 최종 용도별, 지역별 - 산업 예측(2024-2031년)
Nutrigenomics Market Size, Share, Growth Analysis, By Product, By Technique, By Application, By End Use, By Region -Industry Forecast 2024-2031.
상품코드 : 1596861
리서치사 : SkyQuest
발행일 : 2024년 11월
페이지 정보 : 영문 209 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ₩ 7,652,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ₩ 8,951,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ₩ 10,250,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계 영양유전체학 시장 규모는 2022년 3억 8,620만 달러로 2023년 4억 5,379만 달러에서 2031년에는 16억 4,874만 달러로 성장할 것으로 예상되며, 예측 기간(2024-2031년) 동안 17.50%의 CAGR로 성장할 것으로 예상됩니다.

향후 몇 년 동안 세계 영양유전체학 시장은 만성질환의 유병률 증가를 주요 요인으로 성장세를 보일 것으로 예상됩니다. 지난 10년간 단백질체학, 유전체학, 대사체학의 발전으로 단백질 경로를 분석하여 질병을 식별하는 능력이 크게 향상되었으며, 특히 당뇨병, 암, 비만과 같은 식습관 선택에 영향을 받는 질병에 대한 분석 능력이 크게 향상되었습니다. 영양유전체학은 식품과 유전자 발현의 상호 작용을 탐구하여 다양한 식재료가 개인의 유전자 프로필을 어떻게 변화시키는지에 대한 인사이트를 제공합니다. 그러나 유전자 연구 및 검사를 둘러싼 정부 규제가 영양유전체학 제품 및 서비스의 시장 개척을 가로막고 있다는 문제도 제기되고 있습니다. 연방정부, 주정부 또는 지방정부가 시행하는 법규가 강화되면 유전자 검사가 더 까다로워져 임상 관리 및 연구에서의 채택에 영향을 미칠 수 있습니다. 또한, 소비자 직접 의뢰(DTC) 관련 법률이 지역별로 상이하다는 점도 상황을 더욱 복잡하게 만들고 있으며, 이는 영양유전체학 관련 기업들에게 큰 장벽으로 작용하고 있습니다. 결과적으로, 시장 확대의 잠재력이 큰 반면, 규제적 장애물은 혁신적인 영양유전체학 검사 솔루션을 소비자에게 제공하고자 하는 기업들에게 중요한 고려사항이 될 것으로 보입니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

세계의 영양유전체학 시장 규모 : 제품별·CAGR(2024-2031년)

세계의 영양유전체학 시장 규모 : 기술별·CAGR(2024-2031년)

세계의 영양유전체학 시장 규모 : 용도별·CAGR(2024-2031년)

세계의 영양유전체학 시장 규모 : 최종 용도별·CAGR(2024-2031년)

세계의 영양유전체학 시장 규모·CAGR(2024-2031년)

경쟁 정보

주요 기업 개요

결론과 제안

ksm
영문 목차

영문목차

Global Nutrigenomics Market size was valued at USD 386.20 million in 2022 and is poised to grow from USD 453.79 million in 2023 to USD 1648.74 million by 2031, growing at a CAGR of 17.50% during the forecast period (2024-2031).

In the coming years, the global nutrigenomics market is poised for growth, largely driven by the rising prevalence of chronic illnesses. The advancements in proteomics, genomics, and metabolomics over the past decade have significantly enhanced the ability to identify diseases by analyzing protein pathways, especially in conditions like diabetes, cancer, and obesity, which are influenced by dietary choices. Nutrigenomics explores the interplay between food and gene expression, offering insights into how various dietary components can modify an individual's genetic profile. However, the market faces challenges from government regulations surrounding genetic research and testing, which can hamper the development of nutrigenomics products and services. Stricter laws imposed by federal, state, or local authorities can make genetic testing more cumbersome, affecting its adoption in clinical management and research. Additionally, the inconsistency of legislation related to direct-to-consumer (DTC) testing in different regions further complicates the landscape, creating a significant barrier for companies engaged in nutrigenomics. As a result, while there is substantial potential for market expansion, regulatory hurdles will be an important factor to consider for businesses aiming to innovate and bring nutrigenomics testing solutions to consumers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nutrigenomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nutrigenomics Market Segmental Analysis

Global Nutrigenomics Market is segmented into Product, Technique, Application, End Use, and region. By Product, the market is classified into Reagents & Kits, and Services. Depending on the Technique, it is categorized into Saliva, Buccal Swab, Blood. According to Application, the market is divided into Obesity, Cardiovascular Diseases, Cancer Research, Other. Based on End Use, the market is segmented into Hospitals & Clinics, Online Platforms, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Nutrigenomics Market

The global nutrigenomics market is witnessing significant growth driven by the escalating prevalence of chronic diseases, such as obesity, diabetes, and cardiovascular conditions. As these health issues become more prevalent, there is a growing demand for personalized nutrition that takes individual genetic factors into account. This customization of dietary approaches not only aids in the prevention and management of these ailments but also stimulates increased investments in tailored nutrition strategies. Consequently, the focus on nutrigenomics, which integrates genetic insights into dietary planning, is propelling market expansion and offering innovative solutions for better health outcomes globally.

Restraints in the Global Nutrigenomics Market

The global nutrigenomics market encounters significant challenges due to limited scientific evidence supporting the effectiveness of personalized nutrition interventions. While research in this area has shown potential, there remains a lack of extensive clinical validation and large-scale studies that demonstrate the long-term benefits of these solutions. Consequently, this uncertainty leads to skepticism among health care professionals and hesitance among consumers, ultimately impacting the overall acceptability and adoption of nutrigenomic solutions. The absence of robust data to substantiate claims about personalized nutrition hampers the market's growth and poses a considerable restraint on its development on a global scale.

Market Trends of the Global Nutrigenomics Market

The global nutrigenomics market is experiencing a significant trend towards personalized nutrition, driven by advancements in genetic testing and data analytics. Consumers are increasingly seeking tailored dietary solutions that align with their unique genetic profiles, which results in optimized health outcomes and preventive care. This surge is further amplified by the growing awareness of the relationship between genes, diet, and health, alongside increasing consumer demand for personalized health interventions. As companies innovate to offer customized nutritional plans, the market is poised for robust growth, with a wide range of applications in personal health management, chronic disease prevention, and overall wellness enhancement.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Nutrigenomics Market Size by Product & CAGR (2024-2031)

Global Nutrigenomics Market Size by Technique & CAGR (2024-2031)

Global Nutrigenomics Market Size by Application & CAGR (2024-2031)

Global Nutrigenomics Market Size by End Use & CAGR (2024-2031)

Global Nutrigenomics Market Size & CAGR (2024-2031)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendation

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기